|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.44 USD | +2.81% |
|
+0.25% | +1.74% |
| 07-31 | Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing | MT |
| 07-28 | UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 47.33 | +20.32% | 9 | ||||||
| 118.42 | +12.02% | 24 | ||||||
| 98.44 | +14.48% | 25 | ||||||
| 361.42 | +13.93% | 12 | ||||||
| 30,380 | +17.3% | 15 | ||||||
| 181.83 | +6.55% | 12 | ||||||
| 48.54 | +32.38% | 26 | ||||||
| 93.44 | +13.04% | 25 | ||||||
| 404.73 | +15.3% | 15 | ||||||
| 255.38 | +9.74% | 8 | ||||||
| 3,048.46 | +33.24% | 13 | ||||||
| 229.79 | +32.21% | 14 | ||||||
| 102.52 | +4.45% | 21 | ||||||
| 84.69 | -3.18% | 13 | ||||||
| 39.89 | -7.22% | 11 | ||||||
| 28.12 | +2.91% | 12 | ||||||
| 208.6 | +19.32% | 15 | ||||||
| 103.92 | +29.03% | 13 | ||||||
| 325 | -6.57% | 5 | ||||||
| 200.39 | +50.38% | 23 | ||||||
| Average | 1,818.05 | +15.48% | 16 | ||||||
| Weighted average by Cap. | 2,567.29 | +14.36% | 19 |
- Stock Market
- Stocks
- ATRC Stock
- Sector AtriCure, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
